Share Name Share Symbol Market Type Share ISIN Share Description
Anpario Plc LSE:ANP London Ordinary Share GB00B3NWT178 ORD 23P
  Price Change % Change Share Price Shares Traded Last Trade
  0.00 0.0% 620.00 7,628 01:00:00
Bid Price Offer Price High Price Low Price Open Price
600.00 640.00 620.00 620.00 620.00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Food Producers 30.52 5.35 20.63 30.1 144
Last Trade Time Trade Type Trade Size Trade Price Currency
15:59:44 O 3,345 603.00 GBX

Anpario (ANP) Latest News

More Anpario News
Anpario Investors    Anpario Takeover Rumours
Smart Money!
ANP is a large holding in the following funds:
 Fund  Percentage of Fund  Last Updated 
 Downing ONE VCT plc 2.40% 2020-07-31

Anpario (ANP) Discussions and Chat

Anpario Forums and Chat

Date Time Title Posts
07/4/202110:14ANPARIO (formerly Kiotech)1,316
09/9/202010:03Anpario - Natural animal feed producer and distributor in over 80 countries.1
04/11/200810:58Appian Technology1

Add a New Thread

Anpario (ANP) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
2021-04-16 14:59:45603.003,34520,170.35O
2021-04-16 14:40:40614.50112688.24O
2021-04-16 13:51:17614.50111682.10O
2021-04-16 12:53:26605.60318.17O
2021-04-16 11:32:28614.502011,235.15O
View all Anpario trades in real-time

Anpario (ANP) Top Chat Posts

Anpario Daily Update: Anpario Plc is listed in the Food Producers sector of the London Stock Exchange with ticker ANP. The last closing price for Anpario was 620p.
Anpario Plc has a 4 week average price of 560p and a 12 week average price of 537.50p.
The 1 year high share price is 630p while the 1 year low share price is currently 345p.
There are currently 23,150,745 shares in issue and the average daily traded volume is 18,219 shares. The market capitalisation of Anpario Plc is £143,534,619.
partridge1948: An attractive acquisition at sensible price would be another route to growth. ANP sell in I believe over 70 countries, historically through distributors, but in more recent years they have had more success after setting up subsidiaries. They have improved operational performance considerably, so should now be able to cope with sales growth and from what I recall on AGM visit to the factory several years ago there is plenty of room on their site should they want/need to expand. Legislation over use of growth promoting antibiotics should be a good sales tool and we will hopefully see it reflected in the top line numbers this year.
aringadingding: 5 year revenue growth rate of 5.5% per annum is slow, for sure. I am not an expert but are their end markets policy-driven to some extent? Is it fair to hope that e.g. China introduces anti-antibiotic policy? After all antibiotic resistance is a massive global health issue and tangentially but certainly (as a microbial public health issue) related to zoonotic emerging viruses (mentioning no names). I guess there are 3 hopes: 1) They do some good old fashioned business building and marketing and beat a path to their customers' doors 2) Countries introduce policies as per above 3) They get acquired by a company with strong distribution / spare production capacity / threatened by ANP (but not for a few years I would hope) Like I say I'm not an expert but I'm pretty happy to put money into a company with these potential upsides. If others have comments then great.
redwing1: Anpario is a very solid company producing reliable profits and impressive cash flow. The issue has always been revenue growth. Sales have stubbornly refused to move at a pace that justifies such a high rating. Maybe the very resilient performance in a pandemic year is a good omen, but to make meaningful share price progress from here surely requires a prolonged top line surge. It is long overdue.
cfro: Worth noting that according to the final results statement the CEO - Richard Edwards - was paid a bonus of 250k against nothing the year prior. So i would assume he has a chunk of tax to pay on that which might go some way to explaining the share sale. Personally i wouldnt read too much into the director share sales. This is a market after all and every shareholder is entitled to buy or sell accordingly. (Past experience has taught me never to sell on director share sales as it usually is always a costly mistake) What we have is a new BoD and change round. Out with the old and in with the new so to speak. I wouldnt be surprised to see the new directors and board members picking up shares in the weeks and months ahead.
bottomfisher: As a long term shareholder in Anpario I think the recent shares sales by senior executives confirm my view that the current share price has got ahead of itself. Richard Edwards, chief executive, has raised £725,000 selling more than half his stake, at £5.80, and last Autumn, Karen Prior, who is stepping down as finance director but remaining an executive director, raised over £500,000 by selling nearly two thirds of her shares, at around £4. Even Peter Lawrence, who steps down as chairman at the next AGM, has been trimming his stake, selling 5,400 at £4.34 earlier this month. The three directors still retain sizeable stakes: Edwards (88,396 shares), Prior (around 74,000) and Lawrence (57,950), and Anpario has the makings of a great company - all it needs is to start growing much faster than it has done to date. The director share sales make me wonder whether there is any point topping up my own minor stake at current price levels. Let’s hope that Ian Hamilton, Matthew Robinson and Kate Allum, the new non-executive directors, set an example by buying enough shares to at least match one year of their annual directors’ fees.
partridge1948: CEO probably has most of his wealth tied up in ANP and I think has not sold any for 5 or 6 years, but I was rather disappointed to see the size of the sale. Clearly, however, someone was prepared to pay 580p for a decent slug of shares, so I would not read too much into the sale.
aringadingding: Hi all I'm new to the thread but have held this for about a year. I am pretty spooked by both Karen stepping back and the CEO selling over half his stake. Anyone have any views or knowledge on why Karen is stepping back? Below are calcs how how much additional value the CEO would gets for an exit at 800p in 5 years versus 550p, based on shareholdings in 31 Dec 2019 Annual Report: EMIs: At a share price of 550p I make the value of options held £443k. If the share price was to rise to 800p they would be worth £765k. So a difference of £322k. JSOP: CEO 'owns' 1.35m of shares under the JSOP. We are not told the initial market values in the annual report. If the price went from 550p to 800p over 5 years the cost including 4.5% rolled up over 5 years is 685p/shre. Profit is 800-685=115p/shre. 1.35m x 1.15 = £1.55m. (Actually I'm not sure whether the employee is required to purchase these shares when they are issued, and subsequently held by the JSOP, but anyway that's a detail.) Simple shareholding: 88k of shres (as per RNS yesterday not 2019). So £220k of upside between 550p and 800p/shre. Total: 0.322 + 1.55 + 0.22 = £2.092m It's not bad but not amazing either - ? If the company gets acquired he stops getting his salary. Maybe he could time it with his retirement. I do appreciate that with his sale now he may want to e.g. buy a house - thus making him happier to go to work to build company value! With regards to share price valuation and PEG ratio: If one was happy to buy a company on a PE of 16x with 7% EPS growth that is PEG of 2.3x. For Anpario if PE is 27x (=550/20) and growth was 18% (total guess) then that is 1.5x so quite a lot lower actually. So in summary valuation is ok for a growth company but I'm not sure management incentivisation is enough.
cerrito: No surprise that the price dipped with news of the CEO selling comfortably more than half his holding. I note that in closing days of the tax year, so there must have been tax reasons and for all we know he may be buying a large house and/or have family reasons.If he wanted to diversify his financial position, I would be sympathetic. He has a large holding in the JSOP. My feeling is that it has no real impact on my propensity to hold shares in ANP.
cerrito: Comfortable is a good word partridge1948 I was surprised at the initial strength in the share price given the increase we have seen in the last fortnight and the price at the close seems about right.
igoe104: MIDAS SHARE TIPS UPDATE: Healthy animal feed maker Anpario is flying high.
Anpario share price data is direct from the London Stock Exchange
ADVFN Advertorial
Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210417 08:46:18